Chapter 29 - Overview of the Nonclinical Development Strategies and Class Effects of Oligonucleotide-based Therapeutics
| Autor: | Younis, Husam S., Templin, Michael, Whiteley, Laurence O., Kornbrust, Douglas, Kim, Tae-Won, Levin, Arthur A., Henry, Scott P. |
|---|---|
| Zdroj: | In A Comprehensive Guide to Toxicology in Nonclinical Drug Development Edition: Third Edition. 2024:769-790 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|